• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Balkan Med J . Characteristics and Management of Children With COVID-19 in Turkey

tetano

Editor, Senior Moderator
Balkan Med J


. 2020 Aug 31.
doi: 10.4274/balkanmedj.galenos.2020.2020.7.52. Online ahead of print.
Characteristics and Management of Children With COVID-19 in Turkey


Burcu Ceylan Cura Yayla[SUP] 1 [/SUP], Yasemin Ozsurekci[SUP] 2 [/SUP], Kubra Aykac[SUP] 2 [/SUP], Pembe Derin[SUP] 2 [/SUP], Sibel Lacinel G?rlevik[SUP] 2 [/SUP], Sare G Ilbay[SUP] 2 [/SUP], Musa Gurel Kukul[SUP] 2 [/SUP], Sevilay Karahan[SUP] 3 [/SUP], Ali B?lent Cengiz[SUP] 3 [/SUP], Mehmet Ceyhan[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Background: Limited data with regard to disease management strategies is available for paediatric patients with coronavirus disease 2019 (COVID-19), particularly in Turkey.
Aims: We aimed to share the data on patients aged under 18 years in our country to be beneficial for understanding the disease course in children.
Study design: Retrospective cohort study.
Methods: We conducted a retrospective review of the medical records of paediatric patients aged under 18 years, who were confirmed as COVID-19 between March 11, and June 23, 2020, and were admitted to our hospitals.
Results: We evaluated 220 paediatric patients with COVID-19, of which 48.2% were male, with a median age of 10 years, and 9.5% had underlying diseases. Patients were classified according to severity, with the percentages of asymptomatic, mild, moderate, and critical/severe cases determined to be 25.5%, 45%, 26.8%, and 2.7%, respectively. Extracorporeal membrane oxygenation was required for 2 patients (0.9%) and mechanic ventilation was required for 3 patients (1.4%). Targeted therapies were used in 6 patients (2.7%), with hydroxychloroquine being the most commonly used agent either alone (1 patient) or in combination with favipiravir (5 patients). Two patients (0.9%) had died and 9 (4.1%) were still hospitalized during the study period.
Conclusion: Although the disease course of COVID-19 seems to be mild in children, critical illness is significant, and the treatment strategy primarily should consist of supportive care according to our preliminary observations.

Keywords: COVID-19; Turkey; children; favipiravir; immigrant.
 
Back
Top Bottom